IFNγ decreases tumour cell growth in different ways, such as through apoptosis and necroptosis, and by inducing tumour cell cycle arrest, enhancing expression of the cell cycle inhibitor proteins p27Kip, p16, or p21 in different cancers, like breast cancer [119] and hepatocellular cancer [120]. Here, IFNG is linked to neoplasm.